Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery.

Franceschini G, Masetti R.

Am J Surg. 2020 Jan 7. pii: S0002-9610(20)30003-9. doi: 10.1016/j.amjsurg.2020.01.002. [Epub ahead of print]

PMID:
31928777
2.

Oncoplastic Breast-Conserving Surgery: Is Technical Skill All That Is Needed?

Franceschini G, Masetti R.

Ann Plast Surg. 2020 Jan 7. doi: 10.1097/SAP.0000000000002221. [Epub ahead of print] No abstract available.

PMID:
31913889
3.

Successes and Challenges for Diagnosis and Therapy of Acute Leukemia.

Lonetti A, Iacobucci I, Masetti R.

J Oncol. 2019 Nov 22;2019:3408318. doi: 10.1155/2019/3408318. eCollection 2019. No abstract available.

4.

Oncoplastic Breast Reconstruction in Conservation Surgery: Steps to Follow for a Successful Work.

Franceschini G, Masetti R.

Indian J Surg Oncol. 2019 Dec;10(4):660-661. doi: 10.1007/s13193-019-00968-9. Epub 2019 Aug 13. No abstract available.

PMID:
31857761
5.

Menopausal hormone therapy: What should be kept in mind for a personalized choice in a shared decision-making.

Franceschini G, Lello S, Di Leone A, Orlandi A, Masetti R.

Eur J Obstet Gynecol Reprod Biol. 2019 Dec 9. pii: S0301-2115(19)30570-6. doi: 10.1016/j.ejogrb.2019.12.004. [Epub ahead of print] No abstract available.

PMID:
31839443
6.

Enteral Nutrition in Pediatric Patients Undergoing Hematopoietic SCT Promotes the Recovery of Gut Microbiome Homeostasis.

D'Amico F, Biagi E, Rampelli S, Fiori J, Zama D, Soverini M, Barone M, Leardini D, Muratore E, Prete A, Gotti R, Pession A, Masetti R, Brigidi P, Turroni S, Candela M.

Nutrients. 2019 Dec 4;11(12). pii: E2958. doi: 10.3390/nu11122958.

7.

Targeted Therapies for Pediatric AML: Gaps and Perspective.

Lonetti A, Pession A, Masetti R.

Front Pediatr. 2019 Nov 15;7:463. doi: 10.3389/fped.2019.00463. eCollection 2019. Review.

8.

Ontogenic Changes in Hematopoietic Hierarchy Determine Pediatric Specificity and Disease Phenotype in Fusion Oncogene-Driven Myeloid Leukemia.

Lopez CK, Noguera E, Stavropoulou V, Robert E, Aid Z, Ballerini P, Bilhou-Nabera C, Lapillonne H, Boudia F, Thirant C, Fagnan A, Arcangeli ML, Kinston SJ, Diop M, Job B, Lecluse Y, Brunet E, Babin L, Villeval JL, Delabesse E, Peters AHFM, Vainchenker W, Gaudry M, Masetti R, Locatelli F, Malinge S, Nerlov C, Droin N, Lobry C, Godin I, Bernard OA, Göttgens B, Petit A, Pflumio F, Schwaller J, Mercher T.

Cancer Discov. 2019 Dec;9(12):1736-1753. doi: 10.1158/2159-8290.CD-18-1463. Epub 2019 Oct 29.

PMID:
31662298
9.

Personalized medicine in breast cancer: a step forward.

Sanchez AM, Franceschini G, Terribile D, D'Archi S, Scardina L, Masetti R.

Ann Transl Med. 2019 Jul;7(Suppl 3):S138. doi: 10.21037/atm.2019.06.10. No abstract available.

10.

Hormone replacement therapy: revisiting the risk of breast cancer.

Franceschini G, Lello S, Masetti R.

Eur J Cancer Prev. 2019 Sep 16. doi: 10.1097/CEJ.0000000000000548. [Epub ahead of print] No abstract available.

PMID:
31567535
11.

Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?

Sanchez AM, Franceschini G, D'Archi S, De Lauretis F, Scardina L, Di Giorgio D, Accetta C, Masetti R.

Breast J. 2019 Sep 27. doi: 10.1111/tbj.13490. [Epub ahead of print]

PMID:
31562686
12.

Oncoplastic Breast-Conserving Surgery: Is Technical Skill All That Is Needed?

Franceschini G, Masetti R.

Ann Plast Surg. 2019 Sep 12. doi: 10.1097/SAP.0000000000001986. [Epub ahead of print] No abstract available.

PMID:
31524639
13.

Nipple-sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique.

Franceschini G, Visconti G, Garganese G, Barone-Adesi L, Di Leone A, Sanchez AM, Terribile D, Salgarello M, Masetti R.

Breast J. 2019 Sep 9. doi: 10.1111/tbj.13529. [Epub ahead of print]

PMID:
31498531
14.

Comment on "Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer".

Franceschini G, Di Leone A, Masetti R.

Int J Breast Cancer. 2019 Jun 2;2019:4693794. doi: 10.1155/2019/4693794. eCollection 2019. No abstract available.

15.

Re: Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours.

Franceschini G, Masetti R.

ANZ J Surg. 2019 Jun;89(6):786. doi: 10.1111/ans.15269. No abstract available.

PMID:
31179635
16.

Breast-conservation Therapy After Neoadjuvant Chemotherapy: What the Surgeons Should Remember!

Franceschini G, Masetti R.

Am J Clin Oncol. 2019 Jun;42(6):546. doi: 10.1097/COC.0000000000000545. No abstract available.

PMID:
31135565
17.

The changing scenario of non-Down syndrome acute megakaryoblastic leukemia in children.

Masetti R, Guidi V, Ronchini L, Bertuccio NS, Locatelli F, Pession A.

Crit Rev Oncol Hematol. 2019 Jun;138:132-138. doi: 10.1016/j.critrevonc.2019.04.011. Epub 2019 Apr 15. Review.

PMID:
31092368
18.

Longitudinal evaluation of liver stiffness in three pediatric patients with veno-occlusive disease.

Zama D, Bossù G, Ravaioli F, Masetti R, Prete A, Festi D, Pession A.

Pediatr Transplant. 2019 Aug;23(5):e13456. doi: 10.1111/petr.13456. Epub 2019 May 13.

PMID:
31081161
19.

Extreme oncoplastic breast conserving surgery: Is surgical dexterity all that is need?

Franceschini G, Masetti R.

Am J Surg. 2020 Jan;219(1):211-212. doi: 10.1016/j.amjsurg.2019.04.008. Epub 2019 Apr 15. No abstract available.

PMID:
31010577
20.

Steps to follow in oncoplastic breast surgery to optimise oncological and cosmetic outcome.

Franceschini G, Masetti R.

Ann Chir Plast Esthet. 2019 Jun;64(3):283-284. doi: 10.1016/j.anplas.2019.03.006. Epub 2019 Apr 17. No abstract available.

PMID:
31005349
21.

What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers.

Franceschini G, Masetti R.

Eur J Breast Health. 2019 Apr 1;15(2):135-136. doi: 10.5152/ejbh.2019.4651. eCollection 2019 Apr. No abstract available.

22.

Bilateral risk-reducing mastectomy in BRCA mutation carriers: A difficult decision-making.

Franceschini G, Masetti R.

Breast J. 2019 May;25(3):564-565. doi: 10.1111/tbj.13287. Epub 2019 Apr 9. No abstract available.

PMID:
30964221
23.

Gut resistome plasticity in pediatric patients undergoing hematopoietic stem cell transplantation.

D'Amico F, Soverini M, Zama D, Consolandi C, Severgnini M, Prete A, Pession A, Barone M, Turroni S, Biagi E, Brigidi P, Masetti R, Rampelli S, Candela M.

Sci Rep. 2019 Apr 4;9(1):5649. doi: 10.1038/s41598-019-42222-w.

24.

Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome.

Marazzi F, Masiello V, Marchesano D, Boldrini L, Luzi S, Ferrara PE, Amabile E, Piccari D, Landi F, Moschella F, Franceschini G, Masetti R, Mantini G, Valentini V, Smaniotto D.

Tumori. 2019 Aug;105(4):319-330. doi: 10.1177/0300891619839287. Epub 2019 Apr 1.

PMID:
30935295
25.

Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!

Franceschini G, Di Leone A, Masetti R.

Patient Educ Couns. 2019 Aug;102(8):1573-1574. doi: 10.1016/j.pec.2019.03.006. Epub 2019 Mar 15. No abstract available.

PMID:
30905494
26.

Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.

Franceschini G, Di Leone A, Terribile D, Sanchez MA, Masetti R.

Ann Ital Chir. 2019;90:1-2.

PMID:
30872561
27.

Early gut microbiota signature of aGvHD in children given allogeneic hematopoietic cell transplantation for hematological disorders.

Biagi E, Zama D, Rampelli S, Turroni S, Brigidi P, Consolandi C, Severgnini M, Picotti E, Gasperini P, Merli P, Decembrino N, Zecca M, Cesaro S, Faraci M, Prete A, Locatelli F, Pession A, Candela M, Masetti R.

BMC Med Genomics. 2019 Mar 7;12(1):49. doi: 10.1186/s12920-019-0494-7.

28.

"Warning" to postoperative complications when using hemostatic agents!

Franceschini G, Visconti G, Di Leone A, Masetti R.

Acta Neurochir (Wien). 2019 May;161(5):871-872. doi: 10.1007/s00701-019-03863-y. Epub 2019 Mar 1. No abstract available.

PMID:
30824990
29.

Transaxillary Nipple-Sparing Mastectomy, Lymphadenectomy and Direct-to-Implant Submuscular Breast Reconstruction Using Endoscopic Technique: A Step toward the "Aesthetic Mastectomy".

Visconti G, Franceschini G, Barone-Adesi L, Bianchi A, Masetti R, Salgarello M.

Plast Reconstr Surg. 2019 May;143(5):1122e-1123e. doi: 10.1097/PRS.0000000000005542. No abstract available.

PMID:
30807490
30.

What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!

Franceschini G, Di Leone A, Masetti R.

Transl Behav Med. 2019 Jan 29. doi: 10.1093/tbm/ibz006. [Epub ahead of print] No abstract available.

PMID:
30698813
31.

Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!

Franceschini G, Di Leone A, Masetti R.

Am J Surg. 2019 Nov;218(5):1031-1032. doi: 10.1016/j.amjsurg.2019.01.019. Epub 2019 Jan 24. No abstract available.

PMID:
30691675
32.

CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity.

Masetti R, Bertuccio SN, Pession A, Locatelli F.

Br J Haematol. 2019 Feb;184(3):337-347. doi: 10.1111/bjh.15725. Epub 2018 Dec 28. Review.

33.

Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities.

Pession A, Lonetti A, Bertuccio S, Locatelli F, Masetti R.

Expert Opin Ther Targets. 2019 Feb;23(2):87-91. doi: 10.1080/14728222.2019.1559822. Epub 2018 Dec 24. No abstract available.

PMID:
30556755
34.

Characterization of human breast tissue microbiota from core needle biopsies through the analysis of multi hypervariable 16S-rRNA gene regions.

Costantini L, Magno S, Albanese D, Donati C, Molinari R, Filippone A, Masetti R, Merendino N.

Sci Rep. 2018 Nov 15;8(1):16893. doi: 10.1038/s41598-018-35329-z.

35.

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer.

Lammers PE, Dank M, Masetti R, Abbas R, Hilton F, Coppola J, Jacobs I.

Br J Cancer. 2018 Aug;119(3):266-273. doi: 10.1038/s41416-018-0147-1. Epub 2018 Jul 13.

36.

Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5.

Angelucci C, D'Alessio A, Iacopino F, Proietti G, Di Leone A, Masetti R, Sica G.

Oncotarget. 2018 May 11;9(36):24364-24380. doi: 10.18632/oncotarget.25273. eCollection 2018 May 11.

37.

X chromosome gain is related to increased androgen receptor expression in male breast cancer.

Di Oto E, Biserni GB, Varga Z, Morandi L, Cucchi MC, Masetti R, Foschini MP.

Virchows Arch. 2018 Aug;473(2):155-163. doi: 10.1007/s00428-018-2377-2. Epub 2018 May 25.

PMID:
29802469
38.

Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer.

Nicolazzi MA, Carnicelli A, Fuorlo M, Scaldaferri A, Masetti R, Landolfi R, Favuzzi AMR.

Eur Rev Med Pharmacol Sci. 2018 Apr;22(7):2175-2185. doi: 10.26355/eurrev_201804_14752. Review.

39.

Somatic mutations activating Wiskott-Aldrich syndrome protein concomitant with RAS pathway mutations in juvenile myelomonocytic leukemia patients.

Coppe A, Nogara L, Pizzuto MS, Cani A, Cesaro S, Masetti R, Locatelli F, Te Kronnie G, Basso G, Bortoluzzi S, Bresolin S.

Hum Mutat. 2018 Apr;39(4):579-587. doi: 10.1002/humu.23399. Epub 2018 Jan 19.

PMID:
29316027
40.

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.

Lipka DB, Witte T, Toth R, Yang J, Wiesenfarth M, Nöllke P, Fischer A, Brocks D, Gu Z, Park J, Strahm B, Wlodarski M, Yoshimi A, Claus R, Lübbert M, Busch H, Boerries M, Hartmann M, Schönung M, Kilik U, Langstein J, Wierzbinska JA, Pabst C, Garg S, Catalá A, De Moerloose B, Dworzak M, Hasle H, Locatelli F, Masetti R, Schmugge M, Smith O, Stary J, Ussowicz M, van den Heuvel-Eibrink MM, Assenov Y, Schlesner M, Niemeyer C, Flotho C, Plass C.

Nat Commun. 2017 Dec 19;8(1):2126. doi: 10.1038/s41467-017-02177-w.

41.

Metastatic giant malignant phyllodes tumor of the breast.

Sanchez AM, Franceschini G, Di Giorgio D, Masetti R.

Breast J. 2018 May;24(3):416-417. doi: 10.1111/tbj.12960. Epub 2017 Nov 15. No abstract available.

PMID:
29139587
42.

New challenges in multimodal workout of locally advanced breast cancer.

Sanchez AM, Franceschini G, Orlandi A, Di Leone A, Masetti R.

Surgeon. 2017 Dec;15(6):372-378. doi: 10.1016/j.surge.2017.05.006. Epub 2017 Jun 16. Review.

PMID:
28624359
43.

A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Commentary.

Amato A, Aringhieri E, Boccia S, Buccella F, Gorini B, Gramaglia D, Masetti R, Rossi P, Pelicci PG.

Ann Ist Super Sanita. 2017 Apr-Jun;53(2):104-107. doi: 10.4415/ANN_17_02_05.

44.

Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groups.

Creutzig U, Dworzak MN, Zimmermann M, Reinhardt D, Sramkova L, Bourquin JP, Hasle H, Abrahamsson J, Kaspers G, van den Heuvel MM, Reedijk AMJ, De Moerloose B, Locatelli F, Masetti R.

Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26664. Epub 2017 Jun 9.

PMID:
28598536
45.

Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

Locatelli F, Merli P, Pagliara D, Li Pira G, Falco M, Pende D, Rondelli R, Lucarelli B, Brescia LP, Masetti R, Milano GM, Bertaina V, Algeri M, Pinto RM, Strocchio L, Meazza R, Grapulin L, Handgretinger R, Moretta A, Bertaina A, Moretta L.

Blood. 2017 Aug 3;130(5):677-685. doi: 10.1182/blood-2017-04-779769. Epub 2017 Jun 6.

PMID:
28588018
46.

Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.

Cordelli DM, Masetti R, Zama D, Toni F, Castelli I, Ricci E, Franzoni E, Pession A.

Front Pediatr. 2017 May 15;5:105. doi: 10.3389/fped.2017.00105. eCollection 2017. Review.

47.

A giant phyllodes tumor of the breast causing severe disfigurement. A case report.

Franceschini G, Di Giorgio D, D'Archi S, Di Leone A, Sanchez AM, Masetti R.

Ann Ital Chir. 2017 Jan 20;6. pii: S2239253X17026342.

PMID:
28406095
48.

Letter to the Editors: Concerning "Divergent clinical outcomes of alphaglucosidase enzyme replacement therapy in two siblings with infantile-onset Pompe disease treated in the symptomatic or pre-symptomatic state" by Takashi M et al.

Ortolano R, Baronio F, Masetti R, Prete A, Cassio A, Pession A.

Mol Genet Metab Rep. 2017 Mar 7;11:1. doi: 10.1016/j.ymgmr.2017.02.003. eCollection 2017 Jun. No abstract available.

49.

Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.

Buldini B, Rizzati F, Masetti R, Fagioli F, Menna G, Micalizzi C, Putti MC, Rizzari C, Santoro N, Zecca M, Disarò S, Rondelli R, Merli P, Pigazzi M, Pession A, Locatelli F, Basso G.

Br J Haematol. 2017 Apr;177(1):116-126. doi: 10.1111/bjh.14523. Epub 2017 Feb 27.

PMID:
28240765
50.

Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene.

Masetti R, Bertuccio SN, Astolfi A, Chiarini F, Lonetti A, Indio V, De Luca M, Bandini J, Serravalle S, Franzoni M, Pigazzi M, Martelli AM, Basso G, Locatelli F, Pession A.

J Hematol Oncol. 2017 Jan 21;10(1):26. doi: 10.1186/s13045-017-0396-0.

Supplemental Content

Loading ...
Support Center